• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

To screen or not to screen: ongoing debate in the early detection of prostate cancer.

作者信息

Marroquin Joanna Marie

机构信息

Department of Nursing, University of Pennsylvania, Philadelphia, USA.

出版信息

Clin J Oncol Nurs. 2011 Feb;15(1):97-8. doi: 10.1188/11.CJON.97-98.

DOI:10.1188/11.CJON.97-98
PMID:21278045
Abstract

Debate about the use of prostate-specific antigen (PSA) tests to screen prostate cancer in men is ongoing. Prostate cancer is the most common cancer after skin cancer in men and the second most deadly after lung cancer. An elevated PSA level can lead to this cancer's diagnosis and treatment even before the onset of symptoms. However, other causes also can create a high PSA level, which may lead to men being unnecessarily treated for prostate cancer. This article will shed some light on the issue and discuss prostate cancer screening.

摘要

相似文献

1
To screen or not to screen: ongoing debate in the early detection of prostate cancer.
Clin J Oncol Nurs. 2011 Feb;15(1):97-8. doi: 10.1188/11.CJON.97-98.
2
Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?使用前列腺特异性抗原检测筛查前列腺癌：患者是否在做出明智的决策？
J Fam Pract. 1999 Sep;48(9):682-8.
3
PSA and other tissue kallikreins for prostate cancer detection.用于前列腺癌检测的前列腺特异性抗原及其他组织激肽释放酶
Eur J Cancer. 2007 Sep;43(13):1918-26. doi: 10.1016/j.ejca.2007.06.006. Epub 2007 Aug 3.
4
Prostate-specific antigen kinetics in localized and advanced prostate cancer.局限性和晚期前列腺癌中前列腺特异性抗原的动力学
BJU Int. 2009 Mar;103(5):578-87. doi: 10.1111/j.1464-410X.2009.08345.x. Epub 2009 Feb 6.
5
Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.游离前列腺特异性抗原百分比和前列腺特异性抗原密度作为提高前列腺特异性抗原在直肠指检正常且前列腺特异性抗原水平在4.1至10 ng/ml之间的男性早期前列腺癌检测中特异性的方法的比较
J Urol. 1997 Aug;158(2):502-4.
6
Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.通过前列腺特异性抗原筛查在高危前列腺癌家族的无症状男性中检测亚临床癌症。
Clin Cancer Res. 1999 Jun;5(6):1275-9.
7
Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.采用超灵敏化学发光前列腺特异性抗原检测法早期发现复发性前列腺癌。
Urology. 1997 Oct;50(4):573-9. doi: 10.1016/S0090-4295(97)00251-3.
8
Prostate-specific antigen change in the European Randomized Study of Screening for Prostate Cancer, section Rotterdam.欧洲前列腺癌筛查随机研究鹿特丹分部中前列腺特异性抗原的变化
Urology. 2004 Feb;63(2):316-20. doi: 10.1016/j.urology.2003.09.028.
9
Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride.在接受双重 5α-还原酶抑制剂度他雄胺治疗的男性中，血清前列腺特异性抗原用于检测前列腺癌的临床效用得以保留。
J Urol. 2006 May;175(5):1657-62. doi: 10.1016/S0022-5347(05)00984-5.
10
Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).在基于人群的筛查中，前列腺特异性抗原水平为1.0 ng/mL或更低的男性是否需要进行额外检测？（欧洲前列腺癌筛查随机对照试验，鹿特丹部分）
Urology. 2005 Feb;65(2):343-6. doi: 10.1016/j.urology.2004.09.046.